Registration - Consultant

Vertex Pharmaceuticals (Canada) Inc. / Stephanie Levee, Consultant

Registration Information

Client name: Vertex Pharmaceuticals (Canada) Inc.
Lobbyist name: Stephanie Levee, Consultant
Initial registration start date: 2020-10-05
Registration status: Active
Registration Number: 945399-367598

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 4 (2020-10-05 to 2021-04-16)

Registration versions:

Version 1 of 4 (2020-10-05 to 2021-04-16)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Intellectual Property
International Trade
Science and Technology
Taxation and Finance

Subject Matter Details

Policies or Program

Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
The development of a national pharmacare program, including the Canada Drug Agency, a national formulary and a rare diseases strategy

Policies or Program, Regulation

Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada review processes to implement an orphan drug regulatory framework.

Regulation

Amendments to the Patented Medicines Regulations published in Canada Gazette, Part II on August 21, 2019 and June 10, 2020.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Justice Canada (JC)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
20 Bay Street
Suite 1520
Toronto, ON M5J 2N8
Canada

Telephone number: 647-790-1602
Web address: www.vrtx.com

Client representative

Christina Cunningham, Director of Public Affairs - Canada

Parent Company Information

Vertex Pharmaceuticals Incorporated
- 50 Northern Ave
  Boston, MA 02210
  United States of America

Coalition Members Information

Vertex Pharmaceuticals (Canada) Inc. is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Vertex Pharmaceuticals (Canada) Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Vertex Pharmaceuticals (Canada) Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Stephanie Levee | No public offices held

Business address:
150 Metcalfe Street, Suite 604
Ottawa, ON K2S 2L8
Canada

Telephone number: 613-800-8340

Consultant Firm and Address

Firm: 3Sixty Public Affairs Inc.

Address:
150 Metcalfe Street, Suite 604
Ottawa, ON K2P 1P1
Canada

Telephone number: 613-800-8340

Vertex Pharmaceuticals (Canada) Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Vertex Pharmaceuticals (Canada) Inc./	2020-10-05	current

Vertex Pharmaceuticals (Canada) Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Vertex Pharmaceuticals (Canada) Inc. / Stephanie Levee, Consultant

Registration Information

Associated Communications

Version 1 of 4 (2020-10-05 to 2021-04-16)

Version 1 of 4 (2020-10-05 to 2021-04-16)

Subject Matters

Subject Matter Details

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Registration - Consultant

Vertex Pharmaceuticals (Canada) Inc. / Stephanie Levee, Consultant

Version 1 of 4 (2020-10-05 to 2021-04-16)

Subject Matters

Subject Matter Details

Policies or Program

Policies or Program, Regulation

Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address

Vertex Pharmaceuticals (Canada) Inc./

The following names have been used on or after July 2, 2008

Vertex Pharmaceuticals (Canada) Inc.

Stephanie Levee, 3Sixty Public Affairs Inc. (Consultant)